Articles

A pioneer in global cannabis research, Professor Raphael Mechoulam died March 9th, 2023 in Israel at the age of 92.

In Memoriam: Raphael Mechoulam, “Father of Cannabis Research”

The 2023 Portland show will include four tracks–analytical science, medical cannabis, cultivation, psychedelics–plus a discussion on medical cannabis for veterans, and more!

Cannabis Science Conference Returns to Portland, Oregon with Renewed Focus on Analytical, Medical, Cultivation, and Psychedelic Scientific Insights

In early March 2023, the US Justice Department launched an online application for individuals who were pardoned for simple possession of cannabis under President Biden's October 6, 2022 proclamation. Applicants can now receive a certificate of proof of their pardon.

US Justice Department Launches Online Application for Certificate of Proof of Cannabis Possession Pardon

A civil lawsuit filed in Arkansas by a medical cannabis patient alleges that three cannabis growers and one testing laboratory inflated the amount of tetrahydrocannabinol (THC) in numerous cannabis products.

Civil Lawsuit Accuses Arkansas' Largest Cannabis Testing Laboratory of Conspiring with Cultivators to Inflate THC Levels

In early 2023, Yale School of Medicine announced the foundation of a new center for cannabis research. The center’s inaugural director recently provided commentary on the goals and direction of the research.

More Details on Yale University’s New Research Center for Cannabis and Mental Health

Recently, the University of Oxford began an international study to examine the potential therapeutic benefits of cannabidiol (CBD) in treating psychosis or psychotic symptoms.

Cannabidiol for Potentially Treating Psychosis: International Study Launched by University of Oxford

On February 13, 2023, the US Drug Enforcement Administration (DEA) declared in a letter that the cannabinoids delta-8 and -9 THCO are both considered controlled substances due to their chemical structures.

The Drug Enforcement Administration Clarifies That Delta-9-THCO and Delta-8-THCO Are Controlled Substances

The House and Senate introduced a revised bill to mandate Veterans Affairs (VA) to conduct research on the effects of medical cannabis on veterans with post-traumatic stress disorder (PTSD) and chronic pain. 

House and Senate Introduce Bill to Direct Veterans Affairs to Study Medical Cannabis to Treat Certain Conditions

Cannabidiol (CBD) was recently studied in Mexico as a treatment for traumatic brain injury and Parkinson’s Disease.

Recent Studies from Medical Marijuana Inc. Test Cannabidiol for Treatment of Two Conditions

Next month the University of Connecticut (UConn) will hold a two-day cannabis symposium covering a wide variety of topics.

All News